Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) - Join Clinical Trial NCTNCT06788912
How to Join This Clinical Trial - NCTNCT06788912
Learn how to participate in this PHASE2 trial studying an investigational therapy for Lung Neoplasms, Neoplasms. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Lung Neoplasms, Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Lung Neoplasms, Neoplasms
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06788912 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 11 locations. Find a study site near you:
Clinical Research Site
Baltimore, Maryland 21237 - United States
Status: RECRUITING
Clinical Research Site
Santiago., Region M. De Santiago 7500653 - Chile
Status: RECRUITING
Clinical Research Site
Santiago, Region M. De Santiago 7500921 - Chile
Status: RECRUITING
Clinical Research Site
Santiago, Region M. De Santiago 8420383 - Chile
Status: RECRUITING
Clinical Research Site
Firenze, Toscana 50134 - Italy
Status: RECRUITING
Clinical Research Site
Milano, 20132 - Italy
Status: RECRUITING
Clinical Research Site
Gdansk, Pomorskie 80-952 - Poland
Status: RECRUITING
Clinical Research Site
Poznan, Wielkopolskie 60-569 - Poland
Status: RECRUITING
Clinical Research Site
Ankara, 06230 - Turkey
Status: RECRUITING
Clinical Research Site
Cherkasy, Cherkaska Oblast 18009 - Ukraine
Status: RECRUITING
And 1 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Lung Neoplasms, Neoplasms:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships